Skip to content

Carotid Intima Media Thickness (CIMT) in Epistaxis

Carotid Intima Media Thickness in Patients With Epistaxis: a Surrogate Marker for Generalised Atherosclerosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03092973
Enrollment
82
Registered
2017-03-28
Start date
2016-12-01
Completion date
2017-06-30
Last updated
2017-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis, Epistaxis

Brief summary

Epistaxis is a very frequent emergency among adults and often needs specialised treatment in an ENT-department. Among others, atherosclerosis is often named as a reason for an increased risk for Epistaxis. To evaluate whether or not this is the case, the investigators examined the carotid intima media thickness via ultrasound in patients who were treated in the ENT-department of the University Hospital of Zurich.

Interventions

DIAGNOSTIC_TESTUltrasound

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* active or very recently active anterior or posterior epistaxis * at least 18 years old

Exclusion criteria

* posttraumatic or postoperative epistaxis

Design outcomes

Primary

MeasureTime frame
Carotid Intima Media Thickness in Epistaxis vs. ControlsJune 2017

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026